Michael Klentze MD PhD ABAAM
Medical Director, Klentze Institute of Anti-Aging,
Director A4M, USA
Secretary General ESAAM, Vienna
Dr. Michael Klentze received his medical
degree from the University of Munich Medical School and is Board Certified
in psychiatry and gynecology. He is Medical Director of Klentze Institute
of Anti-Aging Medicine in Munich, Germany. An advisory member of the
American Board of Anti-Aging Medicine for Europe, Dr. Klentze holds
membership in the Endocrine Society (USA), the European Committee of
Anti-Aging Medicine, the German Society of Gynecology and Obstetrics,
and the European Menopause Society. He is the author of several scientific
articles on aging-related topics including androgens in women, neurosteroids
and the aging brain and vitamins and antioxidants.
2007 - TBA
PAST AACL CONFERENCES
2006 - Polymorphisms as
tool for individual tailor customed Estrogen and
Testosterone Repleacement - Therapy
This presentation displays the new and approach
to an endocrinological treatment strategy, which should be 1.
individual , 2. custom
attracted and 3. secure. The great advances in medicine in the last
years can realize this idea for the near future. Women
ask more and more after a custom attracted and individualized HRT.
We can observe a change of paradigm in nearly all medical subject
areas. The standard of an individualized therapy for our patients requires
more and more comprehensive epidemiological investigations , meta analyses
and genetically analysis, which is especially supported by the
detection of the human genome.